Malaria killed over 600,000 people in 2022, a death toll that has not improved since 2015.
Additionally, parasites and mosquitoes resistant to existing interventions are spreading …

Feline leukemia virus (FeLV) is one of the most prevalent infectious diseases in domestic
cats. Although different commercial vaccines are available, none of them provides full …

The development of HIV prophylactic vaccines is facing an impasse, since all phase IIb/III
clinical trials were halted in 2023 without demonstrating efficacy. Thus, the field is in need of …

Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) vaccines have been
long overdue. Structure-based vaccine design created a new momentum in the last decade …

Background Neoantigens are patient-and tumor-specific peptides that arise from somatic
mutations. They stand as promising targets for personalized therapeutic cancer vaccines …

The encapsulation of HIV-unrelated T helper peptides into liposomal vaccines presenting
trimers of the HIV-1 envelope glycoprotein (Env) on the surface (T helper liposomes) may …

The influenza virus continues to pose a great threat to public health due to the frequent
variations in RNA viruses. Vaccines targeting conserved epitopes, such as the extracellular …

Virus-like particles (VLPs) have been proposed as an attractive tool in SARS-CoV-2 vaccine
development, both as (1) a vaccine candidate with high immunogenicity and low …

Surface functionalization of nano drug carriers allows for precise delivery of therapeutic
molecules to the target site. This technique involves attaching targeting molecules to the …

The antigen density on the surface of HIV-based virus-like particles (VLPs) plays a crucial
role in the improvement of HIV vaccine potency. HIV VLPs consist of a dense protein core …